Crinetics Pharmaceuticals, Inc. (CRNX)
NASDAQ: CRNX · Real-Time Price · USD
38.51
-0.59 (-1.51%)
At close: Apr 23, 2026, 4:00 PM EDT
38.51
0.00 (0.00%)
After-hours: Apr 23, 2026, 5:08 PM EDT
Crinetics Pharmaceuticals Market Cap
Crinetics Pharmaceuticals has a market cap or net worth of $4.03 billion as of April 23, 2026. Its market cap has increased by 64.27% in one year.
Market Cap
4.03B
Enterprise Value
3.05B
1-Year Change
64.27%
Ranking
Category
Stock Price
$38.51
Market Cap Chart
Since July 18, 2018, Crinetics Pharmaceuticals's market cap has increased from $563.93M to $4.03B, an increase of 615.02%. That is a compound annual growth rate of 28.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 22, 2026 | 4.09B | -7.32% |
| Dec 31, 2025 | 4.42B | -6.84% |
| Dec 31, 2024 | 4.74B | 99.51% |
| Dec 29, 2023 | 2.38B | 141.36% |
| Dec 30, 2022 | 984.73M | -26.50% |
| Dec 31, 2021 | 1.34B | 188.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ligand Pharmaceuticals | 4.56B |
| Amicus Therapeutics | 4.54B |
| Legend Biotech | 4.44B |
| Viking Therapeutics | 3.80B |
| Travere Therapeutics | 3.77B |
| ACADIA Pharmaceuticals | 3.77B |
| Tango Therapeutics | 3.73B |
| NewAmsterdam Pharma Company | 3.62B |